A New York judge on Monday, May 19, 2026, cleared the way for jurors to see explosive evidence — including a gun and a red notebook authorities describe as a manifesto — in the upcoming state murder trial of Luigi Mangione, the 27-year-old accused of gunning down UnitedHealthcare CEO Brian Thompson. The ruling, handed down by Judge Gregory Carro, came as both the state and federal cases against Mangione continue to lurch forward on a collision course that has frustrated his defense team for months.
Mangione, who has pleaded not guilty to all charges in both jurisdictions, is now scheduled to stand trial in Manhattan beginning September 8, 2026, with his separate federal trial pushed to January 2027. Jury selection in the federal case will begin January 5, 2027, with opening statements set for January 25, 2027.
A Killing That Shook Corporate America
The charges stem from the December 2024 killing of Thompson, who was shot dead on a Midtown Manhattan sidewalk outside a hotel where he was set to attend an annual investors conference. The brazen daylight ambush of one of the country’s most prominent healthcare executives triggered a multi-state manhunt that ended five days later when Mangione was arrested at a McDonald’s restaurant in Altoona, Pennsylvania.
Prosecutors say the items recovered from Mangione at the time of his arrest — among them the firearm and a red notebook said to contain writings about his intentions — are central to proving the case. Judge Carro’s evidentiary ruling, detailed in recent court coverage, allows much of that material to be presented to jurors despite a partial suppression victory for the defense.
Mangione faces second-degree murder and eight other counts in the state case, which carries a sentence of 25 years to life if he is convicted of the top charge. In federal court, he faces two counts of stalking and could be sentenced to life in prison.
Dueling Trials, Dueling Judges
The September trial date is the product of months of legal maneuvering between two courthouses just two blocks apart in Lower Manhattan. Mangione’s defense attorneys, Karen Friedman Agnifilo and Marc Agnifilo, have repeatedly warned the courts that mounting simultaneous defenses in parallel prosecutions is untenable.
“Realistically, defense counsel cannot be defending Mr. Mangione in state court on second-degree murder charges that carry a maximum sentence of twenty-five years to life while, at the same time, also reviewing 800 questionnaires for a federal case that carries a maximum life sentence,” the defense argued in seeking to delay the federal proceedings.
The scheduling chaos came to a head on Wednesday, April 1, 2026. That morning, US District Judge Margaret Garnett pushed back federal jury selection to early September to avoid having prospective jurors influenced by the ongoing state trial, which had originally been set to begin June 8.
“There’s a massive press pool and a lot of attention on the state trial which is ongoing just two blocks from here,” Garnett said from the bench, explaining that potential jurors would be filling out questionnaires during the state proceedings.
But just hours later, Carro issued a brief two-paragraph order delaying the state trial to September 8 — the very window Garnett had carved out for federal jury selection. The state judge gave no reason for the move, though it had long been sought by the defense. The result, as court reporters noted, was to reintroduce the exact scheduling conflict the federal judge had just tried to eliminate.
Federal Trial Bumped to 2027
Garnett initially declined to move the federal trial into the new year, but the dueling orders forced her hand. On Thursday, April 2, 2026, she relented and pushed the federal case to January 2027 — the timetable the defense had asked for all along. The revised schedule, confirmed in subsequent reporting, gives Mangione’s lawyers a four-month buffer between the conclusion of the state proceedings and the start of federal jury selection.
Both sides have already notched significant pretrial wins. Garnett previously threw out the portions of the federal case that would have made Mangione eligible for the death penalty. Carro, meanwhile, tossed out an enhancement to the state murder charges that would have classified Mangione’s alleged conduct as terrorism.
What Comes Next
With the evidentiary battles largely settled, attention now shifts to jury selection in Manhattan, where finding impartial jurors in one of the most polarizing criminal cases in recent memory will be a monumental task. Thompson’s killing ignited a national debate over the American health insurance industry, and Mangione has become a polarizing figure — vilified by some, celebrated by others — in ways that promise to complicate voir dire.
Prosecutors are expected to lean heavily on the physical evidence Carro greenlit, including the writings in the red notebook, which they say lay out Mangione’s grievances against the healthcare industry. The defense, meanwhile, has signaled it will challenge the chain of custody and the circumstances under which the items were seized in Altoona.
If convicted on the top state count, Mangione faces 25 years to life. A federal conviction in January 2027 could add a life sentence on top of that. For now, the 27-year-old remains in custody as both sides prepare for a fall courtroom showdown that is expected to draw international attention to Lower Manhattan.
